HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

GF 120918 (Elacridar)

inhibitor of MDR1 PROTEIN; structure given in first source
Also Known As:
Elacridar; GF-120918; GF120918; GF120918A; GG918; N-(4-(2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide
Networked: 64 relevant articles (5 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Beijnen, Jos H: 10 articles (10/2015 - 07/2003)
2. Schinkel, Alfred H: 6 articles (10/2015 - 04/2009)
3. Elmquist, William F: 6 articles (12/2013 - 07/2010)
4. Rosing, Hilde: 4 articles (10/2015 - 10/2004)
5. Agarwal, Sagar: 4 articles (04/2013 - 07/2010)
6. Sane, Ramola: 4 articles (04/2013 - 07/2010)
7. Wagenaar, Els: 3 articles (10/2015 - 11/2012)
8. Tang, Seng Chuan: 3 articles (10/2015 - 01/2012)
9. Brouwer, Kim L R: 3 articles (12/2013 - 10/2010)
10. Mittapalli, Rajendar K: 3 articles (12/2013 - 04/2013)

Related Diseases

1. Glioma (Gliomas)
2. Brain Neoplasms (Brain Tumor)
3. Neoplasm Metastasis (Metastasis)
4. Medulloblastoma
5. Glioblastoma (Glioblastoma Multiforme)

Related Drugs and Biologics

1. P-Glycoprotein
2. gefitinib (Iressa)
3. Cyclin-Dependent Kinase Inhibitor p16
4. imatinib (Gleevec)
5. GF 120918 (Elacridar)
6. Paclitaxel (Taxol)
7. Doxorubicin (Adriamycin)
8. valspodar (PSC 833)
9. Verapamil (Calan)
10. Topotecan (Hycamtin)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Oral Administration